Epivara Inc.
PrivateLast Round
Series C
Jul 31, 2025
Total Funding Raised
$5.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epivara Inc. operates in Healthcare & Life Sciences and is based in Champaign, Illinois. Its latest recorded funding round was a Series C round in July 2025.
Epivara Inc. is a biotechnology company that develops non-surgical, injectable sterilization technologies for companion animals and livestock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epivara Inc. Comparables
Compare Epivara Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SG Endocrine Research, LLC | 78% | |
| Cambridge Animal Health | 76% | |
| NgenLab | 70% |
For institutional investors. Book with your work email.
Epivara Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 31, 2025 | ||||
| Grant | May 3, 2023 | ||||
| Grant | May 11, 2022 | ||||
| Grant | Apr 30, 2021 | ||||
| Grant | Mar 10, 2021 | ||||
Seed | Jun 19, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epivara Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Seed |
| State of Illinois | Grant |
| First Leaf Capital | Seed |
| U.S. Department of Agriculture | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 449% MoM, from 277 to 1.5K.
- May 16, 2026
Monthly visitors grew 65% MoM.
For institutional investors. Book with your work email.
Epivara Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epivara Inc.'s valuation, stock price, and market status.
Is Epivara Inc. a public or private company?
Epivara Inc. is a private company.
What is the current stock price of Epivara Inc.?
Epivara Inc. is a private company, so its shares have no public market price. Caplight tracks Epivara Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epivara Inc. worth (valuation)?
Valuation information for Epivara Inc. is not publicly available.
Can I buy Epivara Inc. stock?
Epivara Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epivara Inc.'s last funding round?
Epivara Inc.'s most recent funding round was Series C on July 31, 2025.
Who are the main investors in Epivara Inc.?
Key investors in Epivara Inc. include gener8tor, State of Illinois, First Leaf Capital, U.S. Department of Agriculture, National Science Foundation.
Will Epivara Inc. IPO soon?
No public IPO plans have been announced for Epivara Inc..
How can I track Epivara Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Epivara Inc.'s shares on secondary markets.